Jack Nathan Medical Corp. (JNHMF)
| Previous close | 0.0000 |
| Open | 0.0241 |
| Bid | 0.0163 x 0 |
| Ask | 0.0361 x 0 |
| Day's range | 0.0241 - 0.0241 |
| 52-week range | 0.0170 - 0.0800 |
| Volume | |
| Avg. volume | 467 |
| Market cap | 2.167M |
| Beta (5Y monthly) | -1.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Jack Nathan Health Announces Voting Results from Annual and Special Shareholders’ Meeting
TORONTO, June 27, 2024--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the "AGM") held on Thursday, June 27, 2024 were approved.
- Business Wire
Jack Nathan Health Announces Its Q1 Fiscal 2025 Financial Results
TORONTO, June 20, 2024--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2025, three months ended April 30, 2024. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
- Business Wire
Jack Nathan Health Announces Its Q4 and Year End Fiscal 2024 Financial Results
TORONTO, April 29, 2024--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2024, and fiscal year ended January 31, 2024. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
